Blog

Giuseppe Caruso: TOO is an easy-to-use composite quality measure that is associated with survival in advanced-stage ovarian cancer

Giuseppe Caruso/X

Oct 11, 2024, 14:34

Giuseppe Caruso: TOO is an easy-to-use composite quality measure that is associated with survival in advanced-stage ovarian cancer

Giuseppe Caruso, Gynecology Oncology Specialist at European Institute of Oncology, shared a post a post on X:

“Textbook oncologic outcome (TOO) is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer.”

Tittle: Textbook oncologic outcome is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer

Authors: Giuseppe Carusoa,b, Carrie L. Langstraata, Amanika Kumara, Michaela E. McGreec, Angela J. Foughtc, Dimitrios Nasioudisd, Giovanni D. Alettib, Nicoletta Colombob, Robert L. Giuntolid and William A. Cliby

advanced-stage ovarian cancer Amanika Kumara Angela J. Foughtc b cancer Carrie L. Langstraata Giuseppe Caruso Giuseppe Carusoa Michaela E. McGreec Nicoletta Colombob OncoDaily Oncology Ovarian Cancer Robert L. Giuntolid Textbook oncologic outcome William A. Cliby

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity